S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 21:10 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today302 insider buys this week · $300.6MCIRO short report next: Sep 15The week ahead

ALKS

Alkermes plc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
46.10
−0.78 −1.66%
USD · Sep 6, 01:17 a.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $7.7BP/E 121.3DIV YIELD FCF YIELD 2.87%REV TTM $1.7B +10.8%NET INCOME $66.1M −81.0%NET DEBT $1B52W 26.52 – 55.22SEC XBRL · TTM TO Invalid Date

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$521K
Net, 90 days
0 / 2
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Sep 3Sep 3Gaffin David Joseph · EVP, CLO, Alkermes, Inc.Sell2,034$48.01$98K
Sep 1Sep 1Hopkinson Craig C. · EVP R&D, Chief Medical OfficerSell9,000$46.99$423K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch ALKS. Know when insiders buy.
One email the day a filing lands. Free.